Medication info
Amozaartan XQ Tablet 5/100/2.5/10 Milligrams

Amozaartan XQ Tablet 5/100/2.5/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletRosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pale pink oval film-coated tablet
Packaging
PTP (Al-Al) - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202502507 · Approved 2025.09.22 · Insurance code 643509010

Summary

Main use
Treatment of hypertension and dyslipidemia (including hypercholesterolemia)
Who takes it
Adults
Adult dose
This drug is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Take this drug whole; do not chew, divide, or crush it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended to adjust the dose using the individual components (amlodipine or losartan) before administering the amlodipine/losartan combination. However, direct switching to the amlodipine/losartan combination may be considered when blood pressure is not controlled with monotherapy using the individual components, as follows: - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose of the amlodipine/losartan combination is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Elderly patients: In elderly patients 75 years of age or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination Administer the rosuvastatin/ezetimibe combination once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 2.5/10mg∼20/10mg once daily. The recommended starting dose is 2.5/10mg or 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (including hypercholesterolemia)

  • Essential hypertension
  • stage 2 hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B proteins
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who require simultaneous administration of Amlodipine and Losartan, as well as Rosuvastatin and Ezetimibe combination. The Amlodipine/Losartan combination is used for the treatment of hypertension and is particularly effective for patients with stage 2 hypertension who have difficulty controlling blood pressure with monotherapy or need combination therapy. Meanwhile, the Rosuvastatin/Ezetimibe combination is used as an adjunct to diet for lowering cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, as well as for increasing levels of good HDL cholesterol. This medication is recommended when there is insufficient response to existing dietary and non-drug therapies for safe administration, and the underlying causes of dyslipidemia must be verified and addressed. Additionally, regular blood lipid tests are necessary to evaluate treatment effects, and timely lipid testing and initiation of treatment are critical in cases of acute coronary events. Overall, this medication is used effectively to manage hypertension and dyslipidemia to improve patients' cardiovascular health.

How to take

Adult dose

This drug is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Take this drug whole; do not chew, divide, or crush it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended to adjust the dose using the individual components (amlodipine or losartan) before administering the amlodipine/losartan combination. However, direct switching to the amlodipine/losartan combination may be considered when blood pressure is not controlled with monotherapy using the individual components, as follows: - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose of the amlodipine/losartan combination is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Elderly patients: In elderly patients 75 years of age or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination Administer the rosuvastatin/ezetimibe combination once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 2.5/10mg∼20/10mg once daily. The recommended starting dose is 2.5/10mg or 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may cause serious harm to the fetus and newborn during pregnancy; thus, it should be discontinued immediately upon confirmation of pregnancy. Precautions are necessary for patients with reduced blood volume, particularly those on diuretics, as they may experience symptoms of hypotension. Muscle-related side effects may occur rarely, and if severe muscle pain or weakness occurs, consult a physician immediately. The medication should not be administered to patients with allergies to any of its components or those with certain medical conditions. It is not recommended for patients with severely impaired liver or kidney function; thus, follow the physician's instructions. Elderly patients and those with hyperkalemia should be observed more carefully when taking this medication. Regular checks of liver function and muscle status during treatment are necessary to monitor for abnormal signs. Dizziness, hypotension, and low blood sugar may occur, so caution is advised when driving or operating machinery. Interactions may occur when combined with other medications, so inform your physician or pharmacist of any concurrent medications. If any adverse reactions are suspected while taking this medication, it is important to consult a healthcare professional immediately for appropriate measures.

Side effects

Craniosynostosis, anuria, hypotension, renal failure, elevated ALT, elevated AST, dermatitis, orthostatic dizziness, syncope, rhabdomyolysis, pancreatic carcinoma, myalgia, pruritus, constipation, discomfort in the upper abdomen, nasopharyngitis, increased C-reactive protein, back pain, facial paralysis, headache, dyspepsia, hypertension, cough, dizziness, fatigue, angioedema, vasculitis, hypotension, vasculitis, weakness, fatigue, pain, weight gain/loss, tension, sensory loss/sensory abnormalities, peripheral neuropathy, syncope, taste disturbances, tremor, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, increased sweating, purpura, skin discoloration, urticaria, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzyme levels, angina pectoris, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, loss of appetite, constipation, toothache, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper limb pain, hip joint pain, joint swelling, knee pain, weakness, shoulder pain, muscular rigidity, arthralgia, arthritis, fibromyalgia, weakness, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory impairment, decreased libido, cognitive impairment, migraine, neuroexcitability, sensory abnormalities, peripheral neuropathy, panic disorder, sleep disturbances, hypersomnolence, tremor, dizziness, dyspnea, bronchitis, pharyngeal discomfort, nasal bleeding, rhinitis, respiratory congestion, chest discomfort, hair loss, dermatitis, dry skin, petechial hemorrhage, erythema, flushing, photosensitivity reaction, itching, rash, sweating, urticaria, blurred vision, burning sensation and pain in the eyes, conjunctivitis, taste disturbances, tinnitus, visual impairment, erectile dysfunction, nocturia, frequent urination, urinary tract infection, angioedema, vasculitis, anaphylaxis-like syndrome, liver function abnormalities, hepatitis, intestinal vascular edema, fatigue, anemia, thrombocytopenia, myalgia, weakness, elevated creatine kinase, taste disturbances, dry cough, erythematous skin lesions, hyperkalemia, hyponatremia, elevated ALT, elevated AST, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, renal failure, ventricular ectopic beats, atrial fibrillation, hypoglycemia, weakness, hunger, cold sweat, tremor, decreased concentration, convulsions, altered consciousness, myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy, myositis, lupus-like syndrome, amnesia, polyneuropathy, peripheral neuropathy, severe muscle weakness, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, exanthematous drug eruption, muscle rupture, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, flushing, fatigue, edema, palpitations, dizziness, drowsiness, abdominal pain, nausea, vasculitis, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, erythematous skin reaction, maculopapular rash, heavy-headedness, heat sensation, decreased glucose tolerance, weakness, lip swelling, eyelid swelling, facial rash, palm peeling, hemolytic phenomena, facial swelling, fever, orthostatic effects, syncope, loss of appetite, toothache, flatulence, anemia, gout, hyperkalemia, hypoglycemia, weight gain, sensory loss, bronchitis, rhinitis, urinary tract infection, angioedema, vasculitis, anaphylaxis, urticaria, rash, erythema multiforme, arthralgia, myalgia, elevated creatine phosphokinase, myopathy, rhabdomyolysis, elevated liver aminotransferase levels, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, sensory abnormalities, cholelithiasis, cholecystitis, chest pain, chest discomfort, edema, weakness, systemic edema, headache, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, dry mouth, discomfort in the solar plexus, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorder, palpitations, congestive heart failure, myocardial ischemia, cough, sputum, runny nose, limb pain, arthralgia, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, itching, upper respiratory infection, conjunctival hyperemia, renal failure, liver function abnormalities, increased serum creatinine, elevated blood pressure, increased blood urea, increased serum creatine phosphokinase, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Pale pink oval film-coated tablet

Package unit

PTP (Al-Al) - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.